Monthly Archives: February 2015

https://www.pinterest.com/tradersreport/

https://www.pinterest.com/tradersreport/ Advertisements

Posted in Uncategorized | Leave a comment

4 of Elon Musk’s Boldest Predictions –

4 of Elon Musk’s Boldest Predictions – Stocks in the News http://www.zacks.com/stock/news/164452/4-of-elon-musks-boldest-predictions A rundown of some of Elon Musk’s most out there predictions over the last few years.

Posted in Uncategorized | Leave a comment

Cyber Security Summit Puts Tech Giants A

Cyber Security Summit Puts Tech Giants Apple, Google, and Facebook in Focus – Stocks in the News http://www.zacks.com/stock/news/164450/cyber-security-summit-puts-tech-giants-apple-google-and-facebook-in-focus President Obama is holding a cyber security summit, and technology giants are definitely in focus as a result.

Posted in Uncategorized | Leave a comment

French President blasted in media for ‘u

French President blasted in media for ‘using public funds’ for his actress lover http://rt.com/news/232383-hollande-french-lover-money/ France’s President Francois Hollande has come under fire for reportedly using state money for transportation and other needs of his actress lover, Julie Gayet, according to … Continue reading

Posted in Uncategorized | Leave a comment

#TSLA #TESLA we told you so. Nice Shortt

#TSLA #TESLA we told you so. Nice Shorttrade. Easy 20 $$$ #tradersreport

Posted in Uncategorized | Leave a comment

http://www.civilpetition.de/kampagne/geg

http://www.civilpetition.de/kampagne/gegen-gebuehrenzwang-rundfunk-beitragspflicht-abschaffen/startseite/aktion/163540Z2493/

Posted in Uncategorized | Leave a comment

Pfizer buying Lake Forest-based Hospira

Pfizer buying Lake Forest-based Hospira for $15.23 billion http://chicagotribune.feedsportal.com/c/34253/f/622812/s/43134ed4/sc/1/l/0L0Schicagotribune0N0Cnews0Cchi0Epfizer0Ehospira0E20A150A20A50Estory0Bhtml0Dtrack0Frss/story01.htm Pharmaceutical giant Pfizer has agreed to buy Lake Forest-based Hospira for about $15.23 billion, saying the Illinois drugmaker will enhance the company’s product portfolio in emerging markets.

Posted in Uncategorized | Leave a comment